AU573574B2 - Immunogenic deteminants of foot and mouth disease virus - Google Patents
Immunogenic deteminants of foot and mouth disease virusInfo
- Publication number
- AU573574B2 AU573574B2 AU25428/84A AU2542884A AU573574B2 AU 573574 B2 AU573574 B2 AU 573574B2 AU 25428/84 A AU25428/84 A AU 25428/84A AU 2542884 A AU2542884 A AU 2542884A AU 573574 B2 AU573574 B2 AU 573574B2
- Authority
- AU
- Australia
- Prior art keywords
- deteminants
- immunogenic
- foot
- disease virus
- mouth disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000710198 Foot-and-mouth disease virus Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/22—Viral peptide or viral protein
- Y10S930/222—Foot and mouth disease related
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/AU1984/000038 WO1984003506A1 (en) | 1983-03-08 | 1984-03-08 | Antigenically active amino acid sequences |
AU25428/84A AU573574B2 (en) | 1983-03-08 | 1984-03-08 | Immunogenic deteminants of foot and mouth disease virus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPF8347 | 1983-03-08 | ||
AU25428/84A AU573574B2 (en) | 1983-03-08 | 1984-03-08 | Immunogenic deteminants of foot and mouth disease virus |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2542884A AU2542884A (en) | 1984-09-20 |
AU573574B2 true AU573574B2 (en) | 1988-06-16 |
Family
ID=3714230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25428/84A Ceased AU573574B2 (en) | 1983-03-08 | 1984-03-08 | Immunogenic deteminants of foot and mouth disease virus |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU573574B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU619826B2 (en) * | 1988-04-22 | 1992-02-06 | Aventis Pharma Deutschland Gmbh | A synthetic vaccine against foot and mouth disease and a process for the preparation thereof |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU592311B2 (en) * | 1984-07-24 | 1990-01-11 | Coselco Mimotopes Pty Ltd | Method for determining mimotopes |
CA1255586A (en) * | 1984-07-24 | 1989-06-13 | Hendrik M. Geysen | Method of determining mimotopes |
WO1986006487A1 (en) * | 1985-04-22 | 1986-11-06 | Commonwealth Serum Laboratories Commission | Method for determining mimotopes |
CA1327096C (en) * | 1985-12-26 | 1994-02-15 | Marta I. Sabara | Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
EP0390612A1 (en) | 1989-03-31 | 1990-10-03 | Synbiotics Corporation | Drug production using non-cross reactive antibodies |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0040922A1 (en) * | 1980-05-12 | 1981-12-02 | Biogen N.V. | DNA sequences, recombinant DNA molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens |
AU1255383A (en) * | 1982-03-26 | 1983-09-29 | Biogen N.V. | Foot and mouth disease viral antigenic peptides |
WO1983003547A1 (en) * | 1982-04-14 | 1983-10-27 | Bittle, James, L. | Synthetic picornavirus antigen |
-
1984
- 1984-03-08 AU AU25428/84A patent/AU573574B2/en not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0040922A1 (en) * | 1980-05-12 | 1981-12-02 | Biogen N.V. | DNA sequences, recombinant DNA molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens |
AU1255383A (en) * | 1982-03-26 | 1983-09-29 | Biogen N.V. | Foot and mouth disease viral antigenic peptides |
WO1983003547A1 (en) * | 1982-04-14 | 1983-10-27 | Bittle, James, L. | Synthetic picornavirus antigen |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU619826B2 (en) * | 1988-04-22 | 1992-02-06 | Aventis Pharma Deutschland Gmbh | A synthetic vaccine against foot and mouth disease and a process for the preparation thereof |
Also Published As
Publication number | Publication date |
---|---|
AU2542884A (en) | 1984-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1255383A (en) | Foot and mouth disease viral antigenic peptides | |
JPS6425800A (en) | T-cell epitope of hepatities b virus nucleocapside protein | |
AU7211787A (en) | Intraocular dosage compositions and method of use | |
GB2103622B (en) | Production of foot and mouth disease vaccine from microbially expressed antigens | |
AU5821286A (en) | Synthetic vaccines for foot and mouth disease | |
PT85760A (en) | Vaccine and method of preparation | |
AU8015587A (en) | 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols | |
AU1631188A (en) | Newcastle disease virus vaccine and method for the application thereof | |
AU7258887A (en) | Encapsulated halogen bleaches and methods of preparation and use | |
AU573574B2 (en) | Immunogenic deteminants of foot and mouth disease virus | |
AU7749687A (en) | Oral sustained release preparation of sodium monofluorophosphate | |
AR243081A1 (en) | Synthetic vaccins against foot and mouth disease and their preparation process | |
IL71470A0 (en) | Novel galenic forms of sulpirid suitable for oral administration and their preparation | |
PT85405A (en) | Method of inhibiting virus replication and disease | |
IL81920A0 (en) | Vaccines and their preparation | |
ZA824174B (en) | Production of foot and mouth disease vaccine from microbially expressed antigens thereof | |
DE3666666D1 (en) | Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same | |
AU585494B2 (en) | Live attenuated human rotavirus vaccine and preparation thereof | |
GB2216122B (en) | Preparation of bromofluoromethane | |
ZA828574B (en) | Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it | |
AU7237087A (en) | Vaccine and implant | |
AU2065488A (en) | The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent | |
ZW26082A1 (en) | Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it | |
AU629103C (en) | Vaccine and method of preparation | |
IL66042A0 (en) | Production of foot and mouth disease vaccine from microbially expressed antigens thereof |